advertisement
Eye 67
Showing records 1 to 25 | Display all abstracts in Eye92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Ding J
Eye 2022; 36: 800-811
92512 Outcome of a low-cost glaucoma drainage device with posterior chamber/pars plana insertion of the tube
Rajamani M
Eye 2021; 35: 901-912
92402 Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
Mergen B
Eye 2021; 35: 3350-3357
92529 Clinical spectrum and treatment outcomes of patients with nanophthalmos
Rajendrababu S
Eye 2021; 35: 825-830
92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Mushtaq Y
Eye 2022; 36: 555-563
92450 Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Tsuchiya S
Eye 2021; 35: 919-928
92107 Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials
Pose-Bazarra S
Eye 2021; 35: 1551-1561
92262 Validation of a portable, non-mydriatic fundus camera compared to gold standard dilated fundus examination using slit lamp biomicroscopy for assessing the optic disc for glaucoma
Upadhyaya S
Eye 2022; 36: 441-447
92467 Virtual clinics for glaucoma care - Patients' and clinicians' experiences and perceptions: a qualitative evaluation
Gunn PJG
Eye 2022; 36: 209-218
91909 Clinical features of microvasculature in subzones of parapapillary atrophy in myopic eyes: an OCT-angiography study
Hu X
Eye 2021; 35: 455-463
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Marta A
Eye 2022; 36: 111-118
91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Kim EW
Eye 2021; 35: 536-543
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Vieira R
Eye 2022; 36: 111-118
91957 Progression patterns of normal-tension glaucoma groups classified by hierarchical cluster analysis
Park HS
Eye 2021; 35: 536-543
92262 Validation of a portable, non-mydriatic fundus camera compared to gold standard dilated fundus examination using slit lamp biomicroscopy for assessing the optic disc for glaucoma
Agarwal A
Eye 2022; 36: 441-447
92467 Virtual clinics for glaucoma care - Patients' and clinicians' experiences and perceptions: a qualitative evaluation
Marks JR
Eye 2022; 36: 209-218
91909 Clinical features of microvasculature in subzones of parapapillary atrophy in myopic eyes: an OCT-angiography study
Shang K
Eye 2021; 35: 455-463
92402 Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration
Ramsey DJ
Eye 2021; 35: 3350-3357
92107 Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials
López-Valladares MJ
Eye 2021; 35: 1551-1561
92601 Evaluating multidisciplinary glaucoma care: visual field progression and loss of sight year analysis in the community vs hospital setting
Panchasara B
Eye 2022; 36: 555-563
92751 The performance of iPad-based noise-field perimeter versus Humphrey Field Analyser in detecting glaucomatous visual field loss
Tecson IC
Eye 2022; 36: 800-811
92512 Outcome of a low-cost glaucoma drainage device with posterior chamber/pars plana insertion of the tube
Ramamurthy C
Eye 2021; 35: 901-912
92450 Glaucoma-related central visual field deterioration after vitrectomy for epiretinal membrane: topographic characteristics and risk factors
Higashide T
Eye 2021; 35: 919-928
92529 Clinical spectrum and treatment outcomes of patients with nanophthalmos
Shroff S
Eye 2021; 35: 825-830
92107 Surgical and laser interventions for pseudoexfoliation glaucoma systematic review of randomized controlled trials
López-de-Ullibarri I
Eye 2021; 35: 1551-1561
